FLT3 ITD and TKD Mutation

Last Modified: 3/25/2019 7:24:27 AM


Specimen Requirements: 5.0 mL Whole Blood in a Lavender Top Tube - EDTA
Minimum Volume: 0.5 mL Whold Blood
Transport & Storage: Temperature/Stability: 7 days Ambient
7 days Refrigerated
Rejection Criteria: Fixed cells • FFPE • Tissue • Primary samples that are older than 14 days
Reference Range:

Please refer to interpretive results

Methodology: Polymerase Chain Reaction-Restriction Fragment Length Polymorphism
Clinical Significance: This test was developed and its performance characteristics determined by the Laboratory for Personalized Molecular Medicine™. It has not been cleared or approved by the U.S. Food and Drug Administration. However, such approval is not required for clinical implementation, and test results have been shown to be clinically useful.

The Laboratory for Personalized Molecular Medicine™ is CLIA certified to perform high complexity testing. FLT3 Mutation Testing is performed pursuant to patents licensed from Takara Bio of Otsu, Japan.
Custom Panel: No

PRODUCTION SCHEDULE

Turn Around Time: 2 days
Days Performed: Monday, Tuesday, Wednesday, Thursday, Friday
Sites Performed: Quest - Chantilly
Other Testing Facility: LabPMM LLC 10222 Barndes Canyon Rd. San Diego, CA
PHL Test Code: FLT3A
EPIC Test Code: LAB3112
Send Out Test Code: 90574
Alternate Test Names: FLT3 ITD & TKD Mutation; FLT3 ITD and TKD
CPT Coding: 81245, 81246

Go back to the top of the page.